• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    511.08 Up 4.57(0.90%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 2,819,557   2,104,745   1,378,477  
    Cost of Revenue205,018  155,355  84,455  
    Gross Profit 2,614,539   1,949,390   1,294,022  
    Operating Expenses
    Research Development1,271,353  859,947  625,554  
    Selling General and Administrative504,755  329,415  210,755  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 838,431   760,028   457,713  
    Income from Continuing Operations
    Total Other Income/Expenses Net(25,312)(231)2,012  
    Earnings Before Interest And Taxes813,119  759,797  459,725  
    Interest Expense37,372  46,437  45,304  
    Income Before Tax775,747  713,360  414,421  
    Income Tax Expense427,673  288,998  (335,848)
    Minority Interest -   -   -  
    Net Income From Continuing Ops314,605  424,362  750,269  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 348,074   424,362   750,269  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 348,074   424,362   750,269  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.